Results 1 to 10 of about 41 (28)
Clinical rationale for the use of various teraflex formulations in osteoarthrosis
Современная ревматология, 2010 The paper provides a rationale for using Teraflex with a manifest symptom-modifying effect in patients with osteoarthritis (OA). It is noted that the use of agents that are potentially able to modify cartilage metabolic processes attracts attention above
Natalia Vladimirovna Chichasova
doaj +5 more sources
Современная ревматология, 2010 Aim: to evaluate the impact of long-term Teraflex therapy on symptoms and quality of life in patients with early stages of gonarthrosis (GA) during a 3-year follow-up. Subjects and methods. Two hundred and forty-four outpatients were examined.
Marina Stanislavovna Svetlova
doaj +5 more sources
Современная ревматология, 2011 Two hundred and forty-four outpatients with gonarthrosis were examined. The time course of arthrosonographic (the height of the articular cartilage, the volume of intraarticular effusion, the width of the joint cleft, and the degree of osteophytosis ...
Marina Stanislavovna Svetlova +3 more
doaj +4 more sources
Паёми Сино, 2019 Objective: Comparative evaluation of the effectiveness of mono- and combined therapy of Teraflex with Ostenile in patients with early and developed primary knee osteoarthritis (OA).
O.R. RIZOEVA +2 more
doaj +3 more sources
Научно-практическая ревматология, 2008 Objective. To assess efficacy, safety and aftereffect duration of continuous and intermittent treatment of patients with knee osteoarthritis with “Teraflex”. Material and methods.
L I Alexeeva +4 more
doaj +2 more sources
Medičnì Perspektivi, 2013 Disturbances of the thyroid status may be negatively reflected on the biological processes underlying orthodontic tooth movement. Research object – in experiment to estimate efficacy of application of drug complex with osteotropic and immunomodulating ...
K. A. Kolesnik +2 more
doaj +4 more sources
Современная ревматология, 2016 Objective: to investigate the clinical efficacy and cardiovascular safety of the combined symptomatic slow-acting drug glucosamine and chondroitin sulfate in patients with osteoarthritis (OA) and hypertension.Subjects and methods.
A. P. Rebrov +2 more
doaj +5 more sources
Efficacy of glucosamine-chondroitin combination (Teraflex) in juvenile temporomandibular joint osteoarthritis: a prospective clinical study. [PDF]
Pediatric Anesthesia and Critical Care Journal (PACCJ)Introduction Juvenile temporomandibular joint (TMJ) osteoarthritis is a progressive inflammatory–degenerative disorder asso- ciated with chronic pain, functional limitation, and re- duced quality of life in adolescents.
E.T. Ahmadov +6 more
doaj +2 more sources
Медицинский совет, 2020 Aim. To evaluate the effectiveness of a fixed combination of honadroitin and glucosamine sulfate (Teraflex, Bayer) in the treatment of osteoarthritis (OA), depending on the molecular phenotype of the disease.Materials and methods.
M. A. Kabalyk
doaj +1 more source
Biophysical parameters of the oral fluid and cells of the buccal epithelium in children with diseases of the thyroid gland in the course of orthodontic treatment of maxillodental anomalies [PDF]
Medičnì Perspektivi, 2014 The thyroid status disturbance may be reflected on the biological processes which underlie orthodontic tooth movement. Aim of research – to study state of the oral fluid and buccal epithelium cells (BEC) in the course of a complex orthodontic treatment ...
Kolesnik K.A., Denga E.M.
doaj +3 more sources